FeesSafety
Pluang+

Solana's tokenized equity share plunges from 71% to 30% as memecoin-stock pairs on rival chains surge.

Market News
07 Sep 2026
Crypto Briefing
View Source
Bearish
Solana's tokenized equity share plunges from 71% to 30% as memecoin-stock pairs on rival chains surge.

Solana's dominance in tokenized equity trading sharply declined from 71% to 30% within two weeks due to the rise of memecoin-stock trading pairs on competing chains like BNB Chain and Robinhood Chain. These rival chains introduced hybrid trading pairs combining memecoins with tokenized stocks, attracting speculative capital and increasing transaction volumes through asset bridging. Despite the drop in market share, Solana has processed over $9.5 billion in tokenized stock volume since July 2025 and maintains a strong user base and lending pools. This shift highlights growing competition in the tokenized equity market and suggests Solana must innovate to regain market share.

More News

Remittix raises $33M, burns 300M RTX tokens, as XRP Ledger update sparks $10 XRP price talk

Remittix raises $33M, burns 300M RTX tokens, as XRP Ledger update sparks $10 XRP price talk

Remittix has raised $33 million and will burn 300 million RTX tokens, reducing supply by 20% ahead of public trading starting November 24, 2026. This token burn and near-cap funding boost scarcity and investor interest. Meanwhile, the XRP Ledger's No...

Market News
Bullish
3 hours ago
XTransfer debuts at Money20/20 USA to boost cross-border B2B payments in Latin America.

XTransfer debuts at Money20/20 USA to boost cross-border B2B payments in Latin America.

XTransfer, a leading global B2B cross-border payment platform, made its first appearance at Money20/20 USA 2026 in Las Vegas to accelerate its expansion into Latin American markets. The company recently completed regulatory registration in Chile, ena...

Market News
Bullish
3 hours ago
Lunit and Summit Therapeutics partner to use AI for tumor analysis in cancer drug development

Lunit and Summit Therapeutics partner to use AI for tumor analysis in cancer drug development

Lunit Inc. and Summit Therapeutics have entered a research agreement to use Lunit's AI-powered pathology platform, Lunit SCOPE IO, for analyzing tumor microenvironments in support of Summit's immuno-oncology drug ivonescimab. The AI platform will ana...

Market News
Bullish
4 hours ago
Virtuals Protocol tests automated options trading for BTC and ETH hedging around US economic data.

Virtuals Protocol tests automated options trading for BTC and ETH hedging around US economic data.

Virtuals Protocol is conducting a private test of Butler's automated options trading on the Derive platform, allowing Bitcoin and Ether holders to hedge against major U.S. economic events like Federal Reserve rate decisions and CPI releases. Users se...

Protocol Fundamentals
Neutral
4 hours ago
Crypto markets face volatility around Nov 3 U.S. midterms; policy shifts unlikely to spark sustained rally.

Crypto markets face volatility around Nov 3 U.S. midterms; policy shifts unlikely to spark sustained rally.

HTX Research forecasts choppy crypto trading before and after the Nov. 3 U.S. midterm elections, noting that changes in congressional control may alter policy expectations but won't alone drive a lasting market rally. Near-term crypto prices are more...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App